Agilent Technologies, Inc. (NYSE:A – Get Free Report) shares passed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $171.13 and traded as low as $169.40. Agilent Technologies shares last traded at $170.0980, with a volume of 1,882,239 shares.
Analyst Ratings Changes
A number of equities research analysts have issued reports on A shares. HSBC upped their price objective on shares of Agilent Technologies from $165.00 to $175.00 and gave the stock a “buy” rating in a research report on Tuesday, September 1st. Evercore lifted their price target on Agilent Technologies from $148.00 to $178.00 and gave the stock an “outperform” rating in a report on Wednesday, October 7th. Sanford C. Bernstein raised their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a report on Thursday, August 27th. The Goldman Sachs Group lifted their price objective on shares of Agilent Technologies from $175.00 to $185.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, October 17th. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $181.45.
Read Our Latest Stock Report on Agilent Technologies
Agilent Technologies Price Performance
The business has a fifty day moving average of $171.13 and a 200-day moving average of $139.19. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The firm has a market cap of $47.96 billion, a PE ratio of 33.48, a PEG ratio of 2.54 and a beta of 1.24.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter last year, the business posted $1.37 earnings per share. The firm’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.
Agilent Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 27th. Shareholders of record on Tuesday, January 5th will be given a dividend of $0.2625 per share. The ex-dividend date is Tuesday, January 5th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.2550. This represents a $1.05 annualized dividend and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.
Insider Activity
In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the transaction, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Hedge Funds Weigh In On Agilent Technologies
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Signature Equity Partners LLC lifted its position in Agilent Technologies by 172.7% during the third quarter. Signature Equity Partners LLC now owns 180 shares of the medical research company’s stock valued at $31,000 after buying an additional 114 shares during the period. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies during the third quarter valued at approximately $32,000. Markowski Investments bought a new stake in shares of Agilent Technologies in the 2nd quarter worth $27,000. Keating Financial Advisory Services Inc. bought a new stake in Agilent Technologies in the 2nd quarter worth about $31,000. Finally, Osterweis Capital Management Inc. bought a new stake in shares of Agilent Technologies in the second quarter worth approximately $43,000.
Agilent Technologies Company Profile
Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
